Syneos Health Schedules Third Quarter 2020 Earnings Call for Thursday, October 29, 2020

Rhea-AI Summary

Syneos Health (Nasdaq:SYNH) will announce its third quarter 2020 financial results on October 29, 2020, before the earnings call at 8:00 a.m. ET. The call will be accessible via webcast on the company's Investor Relations website or by phone using the designated numbers. An audio replay will be available for a week post-call. Syneos Health is a fully integrated biopharmaceutical solutions organization with a global reach, combining clinical and commercial expertise to expedite the delivery of therapies to patients.

Positive

• Scheduled earnings call indicates transparency and communication with investors.
• Presence in over 110 countries enhances market reach and potential growth.

Negative

• No specific financial data or guidance provided ahead of the earnings release, leaving investors uncertain.

MORRISVILLE, N.C., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Syneos Health^® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its third quarter 2020 financial results on Thursday, October 29, 2020, prior to its earnings call at 8:00 a.m. ET.

Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com. To participate via telephone, please dial +1 877 930 8058 within the United States or +1 253 336 7551 outside the United States, approximately 15 minutes prior to the scheduled start time. The conference ID for the call is 4294655.

A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00 p.m. on October 29. In addition, an audio replay will be available for one week following the call and will be accessible by dialing +1 855 859 2056 within the United States or +1 404 537 3406 outside the United States. The replay ID is 4294655.

About Syneos Health
Syneos Health^® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life^®, visit syneoshealth.com or subscribe to our podcast.

Investor Relations Contact:	Press/Media Contact:
Ronnie Speight	Danielle DeForge
Senior Vice President, Investor Relations	Executive Director, External Communications
+1 919 745 2745	+1 781 425 2624
investor.relations@syneoshealth.com	danielle.deforge@syneoshealth.com

FAQ

When will Syneos Health (SYNH) release its Q3 2020 financial results?

Syneos Health will release its Q3 2020 financial results on October 29, 2020.

What time is the earnings call for Syneos Health (SYNH)?

The earnings call for Syneos Health is scheduled for 8:00 a.m. ET on October 29, 2020.

How can I access the earnings call for Syneos Health (SYNH)?

You can access the earnings call via webcast on Syneos Health's Investor Relations website or by dialing the provided phone numbers.

Is there a replay available for Syneos Health's (SYNH) earnings call?

Yes, a webcast replay will be available on the Investor Relations website after 1:00 p.m. on October 29, and an audio replay will be accessible for one week.